TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $175,000 | -65.5% | 364,785 | -3.6% | 0.00% | – |
Q1 2019 | $507,000 | +13.9% | 378,308 | -4.0% | 0.00% | – |
Q4 2018 | $445,000 | -43.3% | 394,141 | +38.6% | 0.00% | – |
Q3 2018 | $785,000 | +13.9% | 284,351 | +47.4% | 0.00% | – |
Q2 2018 | $689,000 | -39.0% | 192,871 | -47.6% | 0.00% | – |
Q1 2018 | $1,130,000 | +22500.0% | 367,901 | +56326.5% | 0.00% | – |
Q2 2017 | $5,000 | -96.9% | 652 | -96.2% | 0.00% | – |
Q1 2017 | $159,000 | +133.8% | 17,269 | +2.3% | 0.00% | – |
Q4 2016 | $68,000 | +183.3% | 16,882 | +172.6% | 0.00% | – |
Q3 2016 | $24,000 | +1100.0% | 6,193 | +1425.4% | 0.00% | – |
Q2 2016 | $2,000 | -95.8% | 406 | -96.1% | 0.00% | – |
Q1 2016 | $48,000 | -84.8% | 10,500 | -66.6% | 0.00% | – |
Q4 2015 | $316,000 | +4.6% | 31,435 | -22.2% | 0.00% | – |
Q3 2015 | $302,000 | -83.5% | 40,411 | +4.8% | 0.00% | -100.0% |
Q2 2015 | $1,830,000 | +7.3% | 38,567 | -17.2% | 0.00% | 0.0% |
Q1 2015 | $1,706,000 | +180.1% | 46,553 | +203.5% | 0.00% | – |
Q4 2014 | $609,000 | – | 15,338 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
Man Group plc | 737,715 | $2,634,000 | 0.01% |